Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...

GLP-1 medications are breakthroughs for weight loss, diabetes ... sold under the brand name Rybelsus, and they're trialing a high-dose version of that pill that could be approved for weight ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...